Earningsreport

Q1/2023 3/31/2023 EPS -0.430 ZacksConsensus -0.420 ActVsEst (0.010) - Miss

Actinium Pharmaceuticals, Inc. (Delaware)  (ATNM) 
NASDAQ:AMEX Investor Relations: ir.actiniumpharma.com